Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 1Disease Progression 1

Interventions

tumor necrosis factor-alpha, CNGRC fusion protein, human 2liposomal doxorubicin 2Doxorubicin 2niraparib 1copanlisib 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Palliative Care 1Paclitaxel 1Lidocaine 1Gemcitabine 1Conservative Treatment 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Conservative Treatment × Gynecologic × Clear all
NCT02522585 2016-04-20

p16 and Ki-67 Stainings and Natural Killer (NK) Cells in CIN-II Management

Parc de Salut Mar

Completed
100 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡